A catheter ablation procedure widely used to treat the most common heart rhythm disorder significantly reduces the burden of atrial fibrillation (AF) and results in clinically important improvements in symptoms and quality of life compared with a sham (placebo) procedure, according to late breaking research presented Sept. 2 in a Hot Line Session at this year’s ESC Congress 2024.
This article was originally published on MedicalXpress.com